Jove
Visualize
Contact Us

Related Experiment Videos

Solid-phase synthesis of thrombin inhibitors.

Udo E W Lange1, Christian Zechel

  • 1BASF AG, D-67056 Ludwigshafen, Germany.

Bioorganic & Medicinal Chemistry Letters
|June 1, 2002
PubMed
Summary

A new solid-phase synthesis method efficiently creates D-Phe-Pro-Arg thrombin inhibitors. These compounds show high potency, inhibiting thrombin effectively in the nanomolar range.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein Substrates.

Journal of chemical information and modeling·2020
Same author

Enzymatic Late-Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groups.

Chemistry (Weinheim an der Bergstrasse, Germany)·2018
Same author

Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors.

Journal of medicinal chemistry·2018
Same author

De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive Inhibitors.

Journal of medicinal chemistry·2018
Same author

Amine Additives Greatly Expand the Scope of Asymmetric Hydrosilylation of Imines.

Angewandte Chemie (International ed. in English)·2018
Same author

Emerging technologies for metabolite generation and structural diversification.

Bioorganic & medicinal chemistry letters·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Biochemistry

Background:

  • Thrombin is a key enzyme in blood coagulation.
  • Developing potent and selective thrombin inhibitors is crucial for anticoagulant therapy.
  • Existing synthesis methods may lack efficiency or broad applicability.

Purpose of the Study:

  • To develop a novel convergent solid-phase synthesis for D-Phe-Pro-Arg type thrombin inhibitors.
  • To synthesize libraries of these potential drug candidates.
  • To evaluate the inhibitory activity of the synthesized compounds against thrombin.

Main Methods:

  • Convergent solid-phase synthesis strategy.
  • Combinatorial library synthesis.
  • Enzyme inhibition assays to determine IC(50) values.

Main Results:

  • Efficient synthesis of D-Phe-Pro-Arg type thrombin inhibitors was achieved.
  • Synthesized libraries contained diverse analogs.
  • Several compounds demonstrated potent thrombin inhibition with IC(50) values in the nanomolar range.

Conclusions:

  • The developed solid-phase synthesis is an effective route to novel thrombin inhibitors.
  • The synthesized D-Phe-Pro-Arg analogs represent promising candidates for anticoagulant drug development.
  • Nanomolar inhibitory activity validates the potential of this compound class.

Related Experiment Videos